Latest On Cellular Biomedicine Group, Inc (CBMG):
About Cellular Biomedicine Group, Inc (CBMG):
Cellular Biomedicine Group, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer and stem cell therapies for degenerative diseases in Greater China. The company develops treatments utilizing proprietary cell based technologies, including immune cell therapy for treating a range of cancer indications comprising technologies in chimeric antigen receptor modified T cells (CAR-T), T-cells with genetically modified, tumor antigen-specific T-cell receptors, and next generation neoantigen-reactive bio-markers based tumor infiltrating lymphocytes; and human adipose-derived mesenchymal progenitor cells for the treatment of joint diseases The company's CAR-T products include CD20 for use in anti-tumor activities; CD22, a surface maker highly expressed in B cell malignancies in hairy cell leukemia; and B-cell maturation antigen therapies for treating refractory multiple myeloma in patients. It also develops NKG2D CAR therapies for use in NK cell signaling; alpha fetoprotein TCR-T therapies for treating hepatocellular carcinoma; tumor infiltrating lymphocyte therapies for treating immunogenic cancers; and knee osteoarthritis therapies, including AlloJoin therapy, which is in a Phase II clinical trial, as well as Re-Join that has completed the Phase IIb clinical trial. In addition, it engages in biopharmaceutical businesses, including research and development, technical support, technical service, and technology transfer activities in biomedical technology field; manufacturing non-food, pharmaceutical polypeptides, and medical devices; and the wholesale of cosmetics, sanitary products, and biological agents. The company has a collaboration agreement with Novartis Pharma AG to manufacture and supply their CAR-T cell therapy Kymriah in China. Cellular Biomedicine Group, Inc. was incorporated in 2001 and is headquartered in New York, New York.
General
- Name Cellular Biomedicine Group, Inc
- Symbol CBMG
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 217
- Last Split Factor1:100
- Last Split Date2013-01-31
- Fiscal Year EndDecember
- IPO Date2014-03-21
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.cellbiomedgroup.com
Valuation
- Price/Sales (Trailing 12 Mt.) 1184.26
- Price/Book (Most Recent Quarter) 22.21
- Enterprise Value Revenue 1258.81
Financials
- Most Recent Quarter 2020-09-30
- Operating Margin -17044%
- Return on Assets -35%
- Return on Equity -130%
- Revenue 322950
- Earnings Per Share -$2.32
- Revenue Per Share $0.02
- Gross Profit 277542
- Quarterly Earnings Growth 1031%
Highlights
- Market Capitalization 384.69 million
- EBITDA -36203524
- Analyst Target Price $19
- Book Value Per Share $0.89
Share Statistics
- Shares Outstanding 19.48 million
- Shares Float 15.23 million
- % Held by Insiders 4470%
- % Held by Institutions 33.84%
- Shares Short 290041
- Shares Short Prior Month 284052
- Short Ratio 3.48
- Short % of Float 3%
- Short % of Shares Outstanding 1%
Technicals
- Beta 1.21
- 52 Week High $19.76
- 52 Week Low $11.9
- 50 Day Moving Average 18.91
- 200 Day Moving Average 18.44
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Cellular Biomedicine Group, Inc (CBMG) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Cellular Biomedicine Group, Inc (CBMG) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-11-09 | $N/A | -$0.88 | -$0.68 | -29.41% |
2020-06-30 | 2020-08-12 | $N/A | -$0.70 | -$0.74 | 5.41% |
2020-03-31 | 2020-05-06 | $N/A | -$0.60 | -$0.76 | 21.05% |
2019-12-31 | 2020-02-28 | $290655 | -$0.66 | -$0.74 | 10.81% |
2019-09-30 | 2019-11-06 | $N/A | -$0.82 | -$0.67 | -22.85% |
2019-06-30 | 2019-08-06 | $N/A | -$0.63 | -$0.52 | -20.39% |
2019-03-31 | 2019-04-30 | $49265 | -$0.51 | -$0.60 | 15% |
2018-12-31 | 2019-02-19 | $25698 | -$0.45 | -$0.37 | -21.62% |
2018-09-30 | 2018-11-06 | $70431 | -$0.72 | -$0.52 | -38.46% |
2018-06-30 | 2018-08-07 | $77313 | -$0.53 | -$0.52 | -1.92% |
2018-03-31 | 2018-05-07 | $50961 | -$0.51 | -$0.47 | -8.51% |
2017-12-31 | 2018-03-05 | $69000 | -$0.48 | -$0.48 | 0% |
2017-09-30 | 2017-11-08 | $107000 | -$0.43 | -$0.48 | 10.42% |
2017-06-30 | 2017-08-08 | $63000 | -$0.43 | -$0.46 | 6.52% |
2017-03-31 | 2017-05-08 | $98000 | -$0.43 | -$0.43 | -0.35% |
2016-12-31 | 2017-03-13 | $58000 | -$0.42 | -$0.43 | 2.33% |
2016-09-30 | 2016-11-08 | $10000 | -$0.75 | ||
2016-06-30 | 2016-08-09 | $72000 | -$0.52 | ||
2016-03-31 | 2016-05-09 | $488000 | -$0.35 | ||
2015-12-31 | 2016-03-14 | $620000 | -$0.43 | -$0.42 | -2.38% |
2015-09-30 | 2015-11-13 | $625000 | -$0.44 | -$0.43 | -2.33% |
2015-06-30 | 2015-08-14 | $657000 | -$0.44 | -$0.37 | -18.92% |
2015-03-31 | 2015-05-18 | $603000 | -$0.39 | -$0.40 | 2.5% |
2014-12-31 | 2015-03-31 | $-1251489 | -$0.57 | -$0.32 | -78.13% |
2014-09-30 | 2014-11-19 | $-118000 | -$0.31 | ||
2014-06-30 | 2014-06-30 | $118000 | -$0.85 | ||
2014-03-31 | 2014-03-31 | $1.7 million | -$0.06 | ||
2013-12-31 | 2013-12-31 | $564802 | -$0.87 | ||
2013-09-30 | 2013-09-30 | $3.19 million | $0.09 | ||
2013-06-30 | 2013-06-30 | $111434 | -$0.44 | ||
2013-03-31 | 2013-03-31 | $N/A | -$1.25 | ||
2012-12-31 | 2012-12-31 | $3.35 million | $285.87 | ||
2012-09-30 | 2012-09-30 | $5.89 million | $3.30 | ||
2012-06-30 | 2012-06-30 | $166771 | -$0.11 | ||
2012-03-31 | 2012-03-31 | $79000 | -$0.16 | ||
2011-12-31 | 2011-12-31 | -$0.01 | |||
2011-09-30 | 2011-09-30 | $3000 | -$0.05 | ||
2011-06-30 | 2011-06-30 | $28000 | -$0.23 | ||
2011-03-31 | 2011-03-31 | -$0.22 | |||
2010-12-31 | 2010-12-31 | $0.94 | |||
2010-09-30 | 2010-09-30 | -$0.13 | |||
2010-06-30 | 2010-06-30 | -$0.25 | |||
2010-03-31 | 2010-03-31 | -$0.70 | |||
2009-12-31 | 2009-12-31 | -$0.17 | |||
2009-09-30 | 2009-09-30 | -$0.10 | |||
2009-06-30 | 2009-06-30 | -$0.16 | |||
2009-03-31 | 2009-03-31 | -$0.16 | |||
2008-12-31 | 2008-12-31 | -$0.54 | |||
2008-09-30 | 2008-09-30 | -$0.09 | |||
2008-06-30 | 2008-06-30 | -$0.14 | |||
2008-03-31 | 2008-03-31 | -$0.11 |
Cellular Biomedicine Group, Inc (CBMG) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Cellular Biomedicine Group, Inc (CBMG) Chart:
Cellular Biomedicine Group, Inc (CBMG) News:
Below you will find a list of latest news for Cellular Biomedicine Group, Inc (CBMG) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Cellular Biomedicine Group, Inc (CBMG) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Cellular Biomedicine Group, Inc (CBMG) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495420007052/0001654954-20-007052-index.htm |
2018-10-19 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1378624/000000000018032859/0000000000-18-032859-index.htm |
2019-05-21 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1378624/000000000019008739/0000000000-19-008739-index.htm |
2019-06-24 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1378624/000000000019010257/0000000000-19-010257-index.htm |
2019-07-03 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1378624/000000000019010750/0000000000-19-010750-index.htm |
2019-07-15 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1378624/000000000019011113/0000000000-19-011113-index.htm |
2019-11-12 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266419004261/0000902664-19-004261-index.htm |
2019-11-13 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266419004285/0000902664-19-004285-index.htm |
2019-11-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000090266419004381/0000902664-19-004381-index.htm |
2019-11-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000090266419004398/0000902664-19-004398-index.htm |
2019-11-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000090266419004399/0000902664-19-004399-index.htm |
2019-11-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000090266419004400/0000902664-19-004400-index.htm |
2020-01-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420000597/0000902664-20-000597-index.htm |
2020-01-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420000598/0000902664-20-000598-index.htm |
2020-02-03 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420000642/0000902664-20-000642-index.htm |
2020-02-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000090266420000664/0000902664-20-000664-index.htm |
2020-02-21 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001296/0000902664-20-001296-index.htm |
2020-02-21 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001297/0000902664-20-001297-index.htm |
2020-02-21 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001298/0000902664-20-001298-index.htm |
2020-02-21 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001299/0000902664-20-001299-index.htm |
2020-02-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001368/0000902664-20-001368-index.htm |
2020-02-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001369/0000902664-20-001369-index.htm |
2020-02-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001370/0000902664-20-001370-index.htm |
2020-02-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001371/0000902664-20-001371-index.htm |
2020-02-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001372/0000902664-20-001372-index.htm |
2020-03-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001666/0000902664-20-001666-index.htm |
2020-04-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001688/0000902664-20-001688-index.htm |
2020-04-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001689/0000902664-20-001689-index.htm |
2020-04-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420001690/0000902664-20-001690-index.htm |
2020-06-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420002501/0000902664-20-002501-index.htm |
2020-06-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420002502/0000902664-20-002502-index.htm |
2020-08-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000090266420002963/0000902664-20-002963-index.htm |
2020-08-14 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000110465920095581/0001104659-20-095581-index.htm |
2020-08-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000110465920095585/0001104659-20-095585-index.htm |
2018-09-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1378624/000112329218000974/0001123292-18-000974-index.htm |
2019-11-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000118518519001621/0001185185-19-001621-index.htm |
2020-02-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000118518520000116/0001185185-20-000116-index.htm |
2020-02-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000118518520000202/0001185185-20-000202-index.htm |
2020-03-31 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000118518520000400/0001185185-20-000400-index.htm |
2020-06-25 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000118518520000892/0001185185-20-000892-index.htm |
2020-08-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000118518520001132/0001185185-20-001132-index.htm |
2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000119312520216973/0001193125-20-216973-index.htm |
2020-08-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1378624/000119312520216977/0001193125-20-216977-index.htm |
2020-08-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1378624/000119312520216988/0001193125-20-216988-index.htm |
2020-10-09 | PREM14A | Preliminary proxy statements relating to merger or acquisition | https://www.sec.gov/Archives/edgar/data/1378624/000119312520266721/0001193125-20-266721-index.htm |
2020-10-09 | SC 13E3 | Going private transaction by certain issuers | https://www.sec.gov/Archives/edgar/data/1378624/000119312520266748/0001193125-20-266748-index.htm |
2018-04-11 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495418003815/0001654954-18-003815-index.htm |
2018-04-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495418003882/0001654954-18-003882-index.htm |
2018-04-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418004095/0001654954-18-004095-index.htm |
2018-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418004234/0001654954-18-004234-index.htm |
2018-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418004477/0001654954-18-004477-index.htm |
2018-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495418004805/0001654954-18-004805-index.htm |
2018-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495418005772/0001654954-18-005772-index.htm |
2018-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495418005773/0001654954-18-005773-index.htm |
2018-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495418005774/0001654954-18-005774-index.htm |
2018-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495418005775/0001654954-18-005775-index.htm |
2018-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495418005776/0001654954-18-005776-index.htm |
2018-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495418005777/0001654954-18-005777-index.htm |
2018-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418006856/0001654954-18-006856-index.htm |
2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495418008569/0001654954-18-008569-index.htm |
2018-09-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418010529/0001654954-18-010529-index.htm |
2018-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418010733/0001654954-18-010733-index.htm |
2018-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418010930/0001654954-18-010930-index.htm |
2018-10-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418010934/0001654954-18-010934-index.htm |
2018-10-10 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1378624/000165495418010954/0001654954-18-010954-index.htm |
2018-10-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1378624/000165495418011402/0001654954-18-011402-index.htm |
2018-10-23 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495418011466/0001654954-18-011466-index.htm |
2018-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418011643/0001654954-18-011643-index.htm |
2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495418012031/0001654954-18-012031-index.htm |
2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418012131/0001654954-18-012131-index.htm |
2018-12-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1378624/000165495418013758/0001654954-18-013758-index.htm |
2018-12-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495418014357/0001654954-18-014357-index.htm |
2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419000126/0001654954-19-000126-index.htm |
2019-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419000251/0001654954-19-000251-index.htm |
2019-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419000542/0001654954-19-000542-index.htm |
2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419000788/0001654954-19-000788-index.htm |
2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495419001593/0001654954-19-001593-index.htm |
2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495419001595/0001654954-19-001595-index.htm |
2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495419001597/0001654954-19-001597-index.htm |
2019-02-19 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1378624/000165495419001756/0001654954-19-001756-index.htm |
2019-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419002157/0001654954-19-002157-index.htm |
2019-03-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1378624/000165495419002827/0001654954-19-002827-index.htm |
2019-03-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1378624/000165495419002829/0001654954-19-002829-index.htm |
2019-03-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495419002988/0001654954-19-002988-index.htm |
2019-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419002990/0001654954-19-002990-index.htm |
2019-03-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419003100/0001654954-19-003100-index.htm |
2019-03-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495419003104/0001654954-19-003104-index.htm |
2019-03-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419003515/0001654954-19-003515-index.htm |
2019-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419004670/0001654954-19-004670-index.htm |
2019-04-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419004765/0001654954-19-004765-index.htm |
2019-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419004939/0001654954-19-004939-index.htm |
2019-04-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495419005054/0001654954-19-005054-index.htm |
2019-05-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419006213/0001654954-19-006213-index.htm |
2019-06-05 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1378624/000165495419007001/0001654954-19-007001-index.htm |
2019-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419007375/0001654954-19-007375-index.htm |
2019-06-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1378624/000165495419007735/0001654954-19-007735-index.htm |
2019-07-01 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1378624/000165495419007858/0001654954-19-007858-index.htm |
2019-07-03 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495419007957/0001654954-19-007957-index.htm |
2019-07-05 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1378624/000165495419007998/0001654954-19-007998-index.htm |
2019-07-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1378624/000165495419008243/0001654954-19-008243-index.htm |
2019-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419008411/0001654954-19-008411-index.htm |
2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495419008900/0001654954-19-008900-index.htm |
2019-08-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419010134/0001654954-19-010134-index.htm |
2019-09-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419010582/0001654954-19-010582-index.htm |
2019-09-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419010612/0001654954-19-010612-index.htm |
2019-09-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419011185/0001654954-19-011185-index.htm |
2019-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419011398/0001654954-19-011398-index.htm |
2019-10-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495419011771/0001654954-19-011771-index.htm |
2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495419011772/0001654954-19-011772-index.htm |
2019-10-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419011839/0001654954-19-011839-index.htm |
2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495419012421/0001654954-19-012421-index.htm |
2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419012516/0001654954-19-012516-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419012639/0001654954-19-012639-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419012712/0001654954-19-012712-index.htm |
2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419013694/0001654954-19-013694-index.htm |
2019-12-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495419014282/0001654954-19-014282-index.htm |
2020-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495420000898/0001654954-20-000898-index.htm |
2020-02-13 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495420001535/0001654954-20-001535-index.htm |
2020-02-13 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495420001538/0001654954-20-001538-index.htm |
2020-02-13 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495420001540/0001654954-20-001540-index.htm |
2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495420001851/0001654954-20-001851-index.htm |
2020-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1378624/000165495420002065/0001654954-20-002065-index.htm |
2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495420003781/0001654954-20-003781-index.htm |
2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495420004551/0001654954-20-004551-index.htm |
2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495420004552/0001654954-20-004552-index.htm |
2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495420004553/0001654954-20-004553-index.htm |
2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495420004554/0001654954-20-004554-index.htm |
2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495420004555/0001654954-20-004555-index.htm |
2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1378624/000165495420004556/0001654954-20-004556-index.htm |
2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1378624/000165495420004651/0001654954-20-004651-index.htm |
2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1378624/000165495420004652/0001654954-20-004652-index.htm |
2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495420004977/0001654954-20-004977-index.htm |
2020-05-08 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/1378624/000165495420005070/0001654954-20-005070-index.htm |
2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495420006859/0001654954-20-006859-index.htm |
2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495420007052/0001654954-20-007052-index.htm |
2020-07-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495420007599/0001654954-20-007599-index.htm |
2020-08-10 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1378624/000165495420008719/0001654954-20-008719-index.htm |
2020-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1378624/000165495420008950/0001654954-20-008950-index.htm |
2020-08-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495420009589/0001654954-20-009589-index.htm |
2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1378624/000165495420011426/0001654954-20-011426-index.htm |
2018-04-09 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1378624/999999999518000787/9999999995-18-000787-index.htm |
2018-10-22 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1378624/999999999518002680/9999999995-18-002680-index.htm |
2019-07-16 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1378624/999999999519001620/9999999995-19-001620-index.htm |
2018-10-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1378624/999999999718008679/9999999997-18-008679-index.htm |
2018-10-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1378624/999999999718008681/9999999997-18-008681-index.htm |
2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1378624/999999999719001303/9999999997-19-001303-index.htm |
2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1378624/999999999719001460/9999999997-19-001460-index.htm |
2019-09-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1378624/999999999719007130/9999999997-19-007130-index.htm |
Cellular Biomedicine Group, Inc (CBMG) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cellular Biomedicine Group, Inc (CBMG). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 4470%Institutional Ownership: 3384%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-04-10 | Wen Tao Liu | Director | Sell | 10,400.00 | 20.10 | 208,988.00 | 213,076.00 | https://www.sec.gov/Archives/edgar/data/1378624/000165495418003882/0001654954-18-003882-index.htm |
2018-04-11 | Wen Tao Liu | Director | Sell | 12,044.00 | 20.08 | 241,843.52 | 213,076.00 | https://www.sec.gov/Archives/edgar/data/1378624/000165495418003882/0001654954-18-003882-index.htm |
2018-04-10 | Wen Tao Liu | Director | Buy | 10,400.00 | 15.53 | 161,512.00 | 223,476.00 | https://www.sec.gov/Archives/edgar/data/1378624/000165495418003882/0001654954-18-003882-index.htm |
2018-04-11 | Wen Tao Liu | Director | Buy | 12,044.00 | 15.53 | 187,043.32 | 225,120.00 | https://www.sec.gov/Archives/edgar/data/1378624/000165495418003882/0001654954-18-003882-index.htm |